Video

The Role of Potassium-Binding Agents in Treating Hyperkalemia

Conference|ASN Kidney Week - American Society of Nephrology Kidney Week

Dr. Cary Boyd-Shiwarski explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.

Pharmacy Times spoke to Dr. Cary Boyd-Shiwarski about her session at the ASN 2021 conference titled "Mechanisms of Potassium Handling in CKD."

Boyd explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.

Related Videos
Image credit: Jack Fotografo | stock.adobe.com
Related Content
NCCN Flash Update: Changes to Colon Cancer Guidelines, Version 3.2025
April 25th 2025

NCCN Flash Update: Changes to Colon Cancer Guidelines, Version 3.2025

Alana Hippensteele, Lead Editor
The RIVAWAR Trial and ACS Guidelines for LV Thrombus
April 22nd 2025

The RIVAWAR Trial and ACS Guidelines for LV Thrombus

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Aislinn Antrim, Managing Editor
Las Vegas strip, Aerial view
April 25th 2025

Asembia's AXS25 Summit: Must-See Sessions, Expert Interviews as Specialty Pharmacy Gathers

Luke Halpern, Assistant Editor
Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange
April 14th 2025

Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange

Alexandra Gerlach, Associate Editor
Health care professional preparing injection -- Image credit: BajimBa | stock.adobe.com
April 25th 2025

The Benefits and Challenges of Subcutaneous Injection in Cancer Care

Alexandra Gerlach, Associate Editor
3D visualization of breast cancer cell metastasis | Image Credit: © freshidea - stock.adobe.com
April 25th 2025

Pyrotinib-Based Therapy May Improve Survival in Patients With HER2+ Breast Cancer and Liver Metastases

Alexandra Gerlach, Associate Editor